Abbott receives FDA approval for its TactiFlex™ Duo Ablation Catheter to treat people with abnormal heart rhythms
On Sept. 8, 2026, Abbott announced it has received U.S. Food and Drug Administration (FDA) approval for the…
-
-
Scientists identify new role for tau protein in brain diseases
On Sept. 8, 2026, researchers from the National Institutes of Health (NIH) found that hyperphosphorylated tau activates reverse…
-
Google DeepMind Launches AlphaGenome Atlas: A predictive map of every possible DNA letter change in the human genome
On Sept. 8, 2026, Google DeepMind released the AlphaGenome Atlas: a platform containing predictions for the effects of…
-
Study Reveals How Toilet Aerosols Reach the Breathing Zone
On Sept. 8, 2026, researchers from Flinders University have found that flushing toilets can release aerosols and bioaerosols…
-
Scientists Complete Full Map of the Fruit Fly Central Nervous System
On Sept. 3, 2026, Janelia scientists and collaborators announced they have completed a wiring diagram of the central…
-
ZANVASTRO™ (zilganersen) approved by the FDA as the first and only disease modifying treatment for Alexander disease (AxD) in pediatric and adult patients
On Sept. 3, Ionis Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved ZANVASTRO™ (zilganersen)…
-
Congo’s Ebola outbreak shows no signs of slowing as deaths top 3,000
On Sept. 2, 2026, the Associated Press reports that Congo’s Ebola outbreak has killed more than 3,000 people…
-
Atlas of the brain’s striatum could guide researchers to new drug treatments
On Sept. 1, 2026, Massachusetts Institute of Technology (MIT) researchers release a study that reveals insights into populations…
-
Vertex Completes Acquisition of Crinetics Pharmaceuticals for $10 Billion
On Sept. 1, 2026, Vertex Pharmaceuticals announced the successful completion of the acquisition of Crinetics Pharmaceuticals, a global…
-
Researchers Discover Dozens of Genes Tied to OCD and Tic Disorders
On Aug. 31, 2026, a Rutgers-led international collaboration has identified 36 genes that substantially raise the risk for…
-
White House Announces Deal with Nine Mid-Size Pharmacutical Companies to Lower Drug Prices
On Aug. 31, 2026, the White House announced agreements with nine- mid-sized pharmaceutical manufacturers to lower prescription drug…
-
Lilly to acquire Merida Biosciences to advance treatments for serious autoimmune and allergic diseases for $2.875 billion in cash
On Aug. 31, 2026, Eli Lilly and Merida Biosciences, a biotechnology company advancing a new class of precision…
-
Northwestern to launch $30 million center to unlock genome’s hidden code
On Aug. 28, 2026, the U.S. National Science Foundation (NSF) announced it has awarded Northwestern University $30 million…
-
Scientific American ranks states by kindergarten vaccination rates
On Aug. 28, 2026, America’s kindergartners are heading back to school less vaccinated than ever. New Centers for…
-
Global initiative launched to improve access to mpox vaccines
On Aug. 27, 2026, a global initiative to establish a stockpile of mpox vaccines was launched creating a…
-
Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine
On Aug. 27, 2026, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) has approved…
-
Largest Molecular Map of Autism Opens Path to Precision Therapies
On Aug. 27, 2026, researchers in the University of California San Francisco (UCSF) School of Pharmacy’s Quantitative Biosciences…
-
Biotechnology | Disease | FDA
Roivant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis
On Aug. 27, 2026, Roivant announced that the U.S. Food and Drug Administration (FDA) has approved LISRAYA™ (brepocitinib)…
-
Biotechnology | FDA | HIV
U.S. FDA Approves Gilead’s Bixlenvo™, a Once-Daily Single Tablet Option for Virologically Suppressed Adults With HIV
On Aug. 27, 2026, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) approved Bixlenvo™ (bictegravir…
-
Researchers searched 1,000 trillion DNA molecules for lead-sensitive DNA – 9 years later, they reported DNA sensors with sensitivity as low as 11 parts per trillion for toxic metals in Drinking Water
On Aug. 26, 2026, researchers at the University of Illinois announce they have developed a DNA lead sensor…
-
Biotechnology | FDA | Oncology
FDA approves new pancreatic cancer drug Offering new treatment
On Aug. 26, 2026, the U.S. Food and Drug Administration (FDA) approved Rasonque (daraxonrasib), a RAS inhibitor for…
-
Pennsylvania Department of Health Confirms Two Measles-Associated Deaths, Both unvaccinated
On Aug. 25, 2026, the Pennsylvania Department of Health (DOH) confirmed two measles-associated deaths in Pennsylvania. Both individuals…
-
Biotechnology | CRO | Medicine
McKesson to Acquire Precision Medicine Group for $2.25 billion
On Aug. 25, 2026, McKesson announced that it signed a definitive agreement to acquire Precision Medicine Group, a…
-
Haisco Signs $1.5 Billion Licensing Deal With Sentivera, A New U.S. Venture
On Aug. 25, 2026, Haisco Pharmaceutical Group announced on that it has entered into an exclusive licensing agreement…
-
CDC | COVID-19 | Disease | Infectious Disease | Influenza | Measles | NIH | Vaccine | Women's Health
latest U.S. Life expectancy data reached or surpassed prepandemic Levels
On Aug. 25, 2026, the U.S. Centers for Disease Control and Prevention (CDC) reported that In 2024, the…
-
FDA approves Johnson & Johnson’s IMAAVY® as first-ever treatment for warm autoimmune hemolytic anemia, a landmark advancement
On Aug. 24, 2026, Johnson & Johnson announced the U.S. Food and Drug Administration (FDA) approval of IMAAVY®…
-
Roche receives FDA clearance for Elecsys® pTau217, advancing Alzheimer’s disease assessment across primary and specialty care
On Aug. 24, 2026, Roche announced that the U.S. Food and Drug Administration (FDA) has cleared the Elecsys®…
-
Wastewater Data Show Texas and Mississippi Driving a Late Summer COVID-19 Uptick
On Aug. 23, 2026, The Centers for Disease Control and Prevention’s (CDC) national wastewater surveillance system, which tracks…
-
Genentech Announces $750 million Manufacturing Expansion in Hillsboro, Oregon
On Aug. 20, 2026, Genentech, a member of the Roche Group, announced plans to invest approximately $750 million…
-
Bill Ackman donates $400 Million from Pershing Square to fund new brain institute
On Aug. 20, 2026, hedge fund billionaire Bill Ackman and his wife, Neri Oxman, announced the were donating…
